GleamWall
中文EN

CBIH Cannabis Bioscience International Holdings, Inc.

Services-Commercial Physical & Biological Research · OTC · SEC CIK 1411057 · Fiscal year ends 05/31

Financial factors as of 2026-02-28 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-64.1%
TTM net income YoY-8.9%
TTM EPS YoY-461.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin78.8%
Operating margin-322.6%
Net margin-416.8%
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-6,272.5%
ROIC (approx.)—
Asset turnover15.05x

Leverage & solvency

Liabilities / assets95,121.4%
Debt / equity—
Current ratio0.00x
Interest coverage-2.68x

Cash quality & payout

Operating cash flow / net income0.52x
Accruals ratio-3,008.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-05-31FY20242024-05-31
Income statement
Revenue$303,022$248,841
Cost of revenue$40,106$45,599
Gross profit$262,916$203,242
SG&A expense$101,906$123,759
Operating income-$421,365-$486,140
Interest expense$136,262$154,206
Income tax—$0
Net income-$548,820-$651,345
EPS (basic)-0.00-0.00
EPS (diluted)-0.00-0.00
Weighted avg. shares (diluted)10.72B10.32B
Balance sheet
Cash & equivalents$12,952$755
Receivables$6,380$20,139
Current assets$29,085$21,492
Total assets$31,880$57,162
Current liabilities$945,963$881,909
Short-term debt$14,592$7,054
Long-term debt$249,500$249,361
Total debt$264,092$256,415
Total liabilities$1.20M$1.14M
Shareholders' equity-$1.16M-$1.08M
Net debt$251,140$255,660
Shares outstanding11.63B10.43B
Cash flow statement
Operating cash flow-$329,627-$479,382
Financing cash flow$341,824$471,224
Stock-based compensation—$0

Free plan shows the latest 2 periods; Pro shows all 3 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.